Search results
30 sty 2020 · Patients identified as black had worse survival than non-black patients, males had worse survival than females, and uninsured patients worse survival than insured patients.
3 paź 2024 · The 5-year survival rate for individuals with noncancerous meningioma (Grade I) is highly positive with 96% for ages 14 years or below, 97% for ages 15 to 39, and 87% for those 40 and above. A person's age at diagnosis and the tumor's grade and location may affect the overall prognosis.
Among the 52 patients with WHO grade 2 disease, survival time ranged from 0.56 to 31.6 years, and 46 patients (88.5%) had >24 months of survival. The median age at the time of diagnosis was 57 years (IQR, 46-70 years), and sex was evenly divided (50% male).
19 sty 2024 · Background. Meningiomas account for ~25% of all primary brain tumors. These tumors have a relatively favorable prognosis with ~92% of meningioma patients surviving >5 years after diagnosis. Yet, patients can report high disease burden and survivorship issues even years after treatment, affecting health-related quality of life (HRQOL).
More than 60% of people with a high grade meningioma survive for 5 years or more after diagnosis. The figures listed above are given in 5 year intervals. This is because doctors use 1, 2, 5 and 10 year intervals for research/measuring purposes.
The relative five-year survival rate for high-grade meningioma is 63.5 percent. However, many factors can affect prognosis. These include the tumor grade and molecular type, the person’s age and health when diagnosed, and how they respond to treatment.
21 kwi 2021 · We investigated 77 consecutive patients who underwent craniotomy for intracranial atypical meningiomas to evaluate predictors of OS and retreatment-free survival, and to assess the benefits of surgical retreatment for subsequent recurrences.
